Abstract #0839
Combined Gadoxetic Acid and Gadofosveset enhanced Liver MRI: Detection and Characterization of Focal Liver Lesions
Peter Bannas 1,2 , Candice A Bookwalter 1 , Tim Ziemlewicz 1 , Utaroh Motosugi 1 , Richard Bruce 1 , Theodora A Potretzke 1 , and Scott B Reeder 1,3
1
Radiology, University of Wisconsin-Madison,
Madison, WI, United States,
2
Radiology,
University Medical Center Hamburg-Eppendorf, Hamburg,
Hamburg, Germany,
3
Medical
Physics, University of Wisconsin-Madison, WI, United
States
On gadoxetic acid enhanced hepatobiliary-phase MRI it
can be challenging to detect small and/or perivascular
focal liver metastases. Moreover, both metastases and
benign cavernous hemangiomas appear hypointense and may
be difficult to distinguish from one another. In this
study we compared hepatobiliary phase MRI for detection
and characterization of liver lesions by using an
intravascular gadolinium based contrast agent,
gadofosveset trisodium, in addition to gadoxetic acid in
78 patients with suspected metastases or hemangiomas.
Our results revealed that combined gadoxetic acid and
gadofosveset enhanced liver MRI improves liver lesion
detection and characterization when compared to
gadoxetic acid alone.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
